APO-Solifenacin solifenacin succinate 5 mg film coated tablets bottle

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

solifenacin succinate, Quantity: 5 mg

MAH:

Arrotex Pharmaceuticals Pty Ltd

INN:

Solifenacin succinate

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: polyvinyl alcohol; lactose; magnesium stearate; iron oxide yellow; hyprolose; macrogol 8000; titanium dioxide; croscarmellose sodium; purified talc

administration_route:

Oral

units_in_package:

30

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

leaflet_short:

Visual Identification: Light yellow coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 5' on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

authorization_status:

Licence status A

authorization_date:

2016-01-12